In keeping with the effect of EZH2 inhibition in tumor cells, Mo-TAMs from EPZ-6438-treated MCS also showed a significantly enhanced expression of CCL2 and VEGF, thus suggesting a potentiation of the circuits favoring TAM accumulation. The gene discussed is EZH2; the disease is neoplasm.